Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)22-23
Number of pages2
JournalNature Clinical Practice Oncology
Volume1
Issue number1
DOIs
Publication statusPublished - Nov 2004

Keywords

  • Blood transfusion
  • Erythropoietin
  • Granulocyte-colony-stimulating factor
  • Neuroblastoma

ASJC Scopus subject areas

  • Oncology

Cite this